Finch Therapeutics Group
A clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs. Learn more
Launch date
Employees
Market cap
€17.0m
Enterprise valuation
€29m (Public information from Sep 2024)
Share price
$11.65 FNCH
Somerville Massachusetts (HQ)
Authorizing premium user...